We read the fine print on 40+ telehealth platforms so you don't have to. What you'll actually pay, which fees are hiding, and the questions to ask before you hand anyone your card.
Twenty-five pages built from actual checkout terms, refund policies and fee schedules — not homepages. Free to download — just tell us where to send it.
Educational content only. Not medical advice, and not a substitute for a conversation with a licensed clinician.
Scored against the same six criteria. Tap Details on any provider for the full breakdown, company info and recent reviews.
Scores reflect our published criteria applied to publicly available terms as of the date shown. Prices change frequently — verify on the provider's own site before purchasing.
The report above is free to everyone. Enter your details once to unlock the full companion library — the ebooks, the COA checklist, and the Five Questions card. Instant access, nothing to pay.
The full story behind the pricing games, the compounding grey market, and how to protect yourself. The book version of everything on this page.
Built for days when nothing sounds good. Small portions, big protein numbers, so you keep muscle while your appetite is suppressed.
One page. The single skill that protects you from an unverified injectable.
Expose a rogue provider in about ninety seconds. Screenshot it, use it on anyone.
Enter your details once and get instant access to every guide on the left — the ebooks, the COA checklist, and the Five Questions card.
Ratings and reviews from people who used the framework before they picked a provider.
Based on 30,000+ verified reader reviews
Almost signed up off a $99 ad. Turns out my real cost for the year was around $2,700. Switched providers and saved close to a grand. Wish I found this sooner.
The insurance tip paid off in one call. Was told twice my plan did not cover it — it did, with a prior auth. Went from $250 to $25 a month.
The 5 questions are clutch. Asked 3 companies who actually compounds the meds — one answered, two ghosted me. Wish the list was a bit longer.
Finally get why the same med is $99 one place and $1,300 another. Clicked in about 5 minutes. No hype.
Really useful, the COA checklist especially. Bit long to get through, but I knew exactly what to ask after.
Honest and to the point. No pushy upsells. The provider comparison alone was worth it.
Reader-submitted comments about the report itself. Not claims about medication results, and not endorsements of any provider listed on this page.
It's genuinely free — there's no cost, no trial and no card required. We just ask for an email so we can send it to you (and let you know when it's updated). If you'd rather use the framework and ignore every link on the site, that's a completely reasonable thing to do — the framework is the valuable part.
Two reasons, and we'd rather say both. First, cheapest headline price is not cheapest annual cost once you account for dose tiers, consult fees and promo resets — that's the entire point of our pricing breakdown. Second, our ranking weighs clinical oversight, pharmacy transparency, support and terms alongside price — so the lowest sticker price doesn't automatically finish first. Use our criteria to judge for yourself, including on providers we don't list.
No. We don't prescribe, compound, dispense or ship medication, and we have no ownership stake in any company named on this page. We're a consumer research desk covering the metabolic health market.
You should get an answer in writing. The FDA declared the semaglutide shortage resolved in February 2025 and moved in April 2026 to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list. That removes the legal basis for large-scale compounding. Email your provider today and ask what happens to your prescription and your rate when their compounding source stops. Part 3 covers exactly what to ask.
Read what that label is telling you. "Not for human consumption" is not a technicality and it is not a wink — it means the product was never made to pharmaceutical standards, never prescribed, and never tested for purity, sterility, endotoxin load or correct concentration. If you take one section from the report, take Part 7.
Published GLP-1 trials report average reductions in the range of roughly 15-22% of body weight depending on the medication and dose, over a period of about a year or more. That's a population average, not a prediction — individual results vary widely based on dose, duration, starting point and a dozen clinical factors. Treat any number you see as a rough frame of reference, not a promise.
Twenty-five pages, free. Enter your email and we'll send it over — with the companion guides free as they land.